Voyager Therapeutics (VYGR) Change in Acquisitions & Divestments (2016 - 2025)
Voyager Therapeutics (VYGR) has disclosed Change in Acquisitions & Divestments for 9 consecutive years, with $118.8 million as the latest value for Q1 2025.
- Quarterly Change in Acquisitions & Divestments rose 8.06% to $118.8 million in Q1 2025 from the year-ago period, while the trailing twelve-month figure was $286.3 million through Mar 2025, up 46.8% year-over-year, with the annual reading at $262.0 million for FY2025, 30.02% down from the prior year.
- Change in Acquisitions & Divestments hit $118.8 million in Q1 2025 for Voyager Therapeutics, up from $109.9 million in the prior quarter.
- In the past five years, Change in Acquisitions & Divestments ranged from a high of $118.8 million in Q1 2025 to a low of $22.6 million in Q2 2021.
- Historically, Change in Acquisitions & Divestments has averaged $71.6 million across 3 years, with a median of $72.5 million in 2021.
- Biggest YoY gain for Change in Acquisitions & Divestments was 50.88% in 2021; the steepest drop was 68.33% in 2021.
- Year by year, Change in Acquisitions & Divestments stood at $22.6 million in 2021, then soared by 385.72% to $109.9 million in 2024, then increased by 8.06% to $118.8 million in 2025.
- Business Quant data shows Change in Acquisitions & Divestments for VYGR at $118.8 million in Q1 2025, $109.9 million in Q1 2024, and $22.6 million in Q2 2021.